138 related articles for article (PubMed ID: 31741633)
1. Inhibition of γ/β Globin Gene Switching in CD 34
Taghavi SA; Hosseini KM; Tamaddon G; Kasraian L
Indian J Hematol Blood Transfus; 2019 Oct; 35(4):758-764. PubMed ID: 31741633
[TBL] [Abstract][Full Text] [Related]
2. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Transcriptional γ-globin Gene Silencing by Inducing The Hereditary Persistence of Fetal Hemoglobin Point Mutation Using Chimeraplast-Mediated Gene Targeting.
Ranjbaran R; Nikogoftar Zarif M; Sharifzadeh S; Golafshan H; Pourfathollah AA
Cell J; 2018 Oct; 20(3):318-325. PubMed ID: 29845784
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a-3p-mediated inhibition of BCL11A upregulates γ-globin expression and inhibits oxidative stress and apoptosis in erythroid precursor cells.
Li H; Lin R; Li H; Ou R; Wang K; Lin J; Li C
Hematology; 2022 Dec; 27(1):1152-1162. PubMed ID: 36178486
[TBL] [Abstract][Full Text] [Related]
5. The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment.
Mahmoud Ahmed NH; Lai MI
Cardiovasc Hematol Disord Drug Targets; 2023; 22(4):226-236. PubMed ID: 36734897
[TBL] [Abstract][Full Text] [Related]
6. BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells.
Li J; Lai Y; Shi L
Hemoglobin; 2018 Jul; 42(4):225-230. PubMed ID: 30821197
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-486-3p regulates γ-globin expression in human erythroid cells by directly modulating BCL11A.
Lulli V; Romania P; Morsilli O; Cianciulli P; Gabbianelli M; Testa U; Giuliani A; Marziali G
PLoS One; 2013; 8(4):e60436. PubMed ID: 23593217
[TBL] [Abstract][Full Text] [Related]
8. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A.
Xu J; Bauer DE; Kerenyi MA; Vo TD; Hou S; Hsu YJ; Yao H; Trowbridge JJ; Mandel G; Orkin SH
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6518-23. PubMed ID: 23576758
[TBL] [Abstract][Full Text] [Related]
9. miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
Simbula M; Manchinu MF; Mingoia M; Pala M; Asunis I; Caria CA; Perseu L; Shah M; Crossley M; Moi P; Ristaldi MS
Mol Ther Nucleic Acids; 2023 Dec; 34():102025. PubMed ID: 37744176
[TBL] [Abstract][Full Text] [Related]
10. Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype.
Brendel C; Guda S; Renella R; Bauer DE; Canver MC; Kim YJ; Heeney MM; Klatt D; Fogel J; Milsom MD; Orkin SH; Gregory RI; Williams DA
J Clin Invest; 2016 Oct; 126(10):3868-3878. PubMed ID: 27599293
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect of Simvastatin and Romidepsin on Gamma-globin Gene Induction.
Habibi H; Atashi A; Abroun S; Noruzinia M
Cell J; 2019 Jan; 20(4):576-583. PubMed ID: 30124006
[TBL] [Abstract][Full Text] [Related]
12. Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.
Liu B; Brendel C; Vinjamur DS; Zhou Y; Harris C; McGuinness M; Manis JP; Bauer DE; Xu H; Williams DA
Mol Ther; 2022 Aug; 30(8):2693-2708. PubMed ID: 35526095
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wonkam A
Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Engraftment and Fetal Globin Induction upon
Chang KH; Smith SE; Sullivan T; Chen K; Zhou Q; West JA; Liu M; Liu Y; Vieira BF; Sun C; Hong VP; Zhang M; Yang X; Reik A; Urnov FD; Rebar EJ; Holmes MC; Danos O; Jiang H; Tan S
Mol Ther Methods Clin Dev; 2017 Mar; 4():137-148. PubMed ID: 28344999
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major.
Psatha N; Reik A; Phelps S; Zhou Y; Dalas D; Yannaki E; Levasseur DN; Urnov FD; Holmes MC; Papayannopoulou T
Mol Ther Methods Clin Dev; 2018 Sep; 10():313-326. PubMed ID: 30182035
[TBL] [Abstract][Full Text] [Related]
16. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34
Khan F; Ali H; Musharraf SG
Eur J Pharmacol; 2022 Jul; 927():175036. PubMed ID: 35618038
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Buch T; Karimipoor M
Data Brief; 2020 Feb; 28():104974. PubMed ID: 31890812
[TBL] [Abstract][Full Text] [Related]
20. BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression.
Gasparello J; Fabbri E; Bianchi N; Breveglieri G; Zuccato C; Borgatti M; Gambari R; Finotti A
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]